Displaying 25 (all) recruiting clinical trials.
-
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor ...
Phase
Interventional
-
HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS
If your child has been diagnosed with medulloblastoma or other central nervous system embryonal tumors, your child may qualify to participate in a study. The ...
Phase
Interventional
-
Camp High 5 2016: Evaluation of the Effect on Upper Limb Function
This study is looking to determine the benefits of a program forcing use of your child's weaker arm/hand followed by bi manual training ...Phase N/A Interventional
-
Correlation of clinical response of children with short stature to growth hormone therapy and composition of the gut microbiome.
There are normally bacteria present in everyone's gut. The purpose of this study is to evaluate if the subjects with short stature have different ...Phase N/A
Non-Interventional
Accepts Healthy Volunteer
-
WUH: A phase 3 long term open-label trial investigating safety and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency (GHD) who have completed a prior Transcon hGH trial.
This is a multicenter, phase 3, long-term, open-label extension trial of weekly TransCon hGH in children with Growth Hormone Deficiency (GHD) who previously participated in ...Phase
Interventional
-
NN8640-4245 - A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin in children with short stature born small for gestational age with no catch-up growth by 2 years of age or older
This research study involves children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day. Researchers will ...Phase
Interventional
-
A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin in children with growth hormone deficiency
Purpose of the research study is to collect information to help us understand how doctors treat and manage children and adolescent with growth hormone deficiency ...Phase
Interventional
-
Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants
The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, and blood) and stool samples are associated ...Phase N/A Non-Interventional
-
Cold milk as a novel therapy for dysphagia in preterm infants
This is a research study to evaluate if drinking cold milk (breast milk or formula at 4-9°C Temp) improves swallowing in premature babies who ...Phase N/A Interventional
-
Gut Microbiome in Food Protein-Induced Enterocolitis Syndrome: An Observational Study
Food protein-induced enterocolitis syndrome (FPIES) is a non IgE-mediated gastrointestinal food allergy that causes severe, projectile, repetitive vomiting in infants and may cause dehydration and ...Phase N/A Non-Interventional
